Health Product InfoWatch – September 2017
ISSN 2368-8025
Pub. no 160256
Health Products and Food Branch
Marketed Health Products Directorate
Health Product InfoWatch Editorial Team
Scope, reporting and contact information, helpful links
Contents
Health products mentioned in this issue
Pharmaceuticals and Biologics
Aubagio (teriflunomide)
Desloratadine
Effient (prasugrel)
Hydroquinone
Keppra (levetiracetam)
Rifadin (rifampin)
Other
Foreign health products
Unauthorized health products
Monthly recap of health product safety information
The following is a list of health product advisories, type I recalls as well as summaries of completed safety reviews published in August 2017 by Health Canada.
Aubagio (teriflunomide)
This safety review evaluated the risk of acute renal injury or nephrolithiasis associated with Aubagio (teriflunomide). Health Canada’s review of the available information did not establish a link. Health Canada will continue to monitor this issue.
Summary Safety Review - Aubagio (teriflunomide)
Desloratadine
This safety review evaluated the risk of QT interval prolongation associated with desloratadine. Health Canada’s review of the available information did not establish a link. Health Canada will continue to monitor this issue.
Summary Safety Review - Desloratadine
Effient (prasugrel)
This safety review evaluated the risk of severe cutaneous adverse reactions associated with Effient (prasugrel). Health Canada’s review concluded that there was not enough information available to establish a link. Health Canada will continue to monitor this issue.
Summary Safety Review - Effient (prasugrel)
Foreign health products
These foreign health products have been found by regulators in other countries to contain undeclared drug ingredients. The products are not authorized for sale in Canada and have not been found in the Canadian marketplace, but it is possible they may have been brought into the country by travellers or purchased over the Internet.
Hydroquinone
Hydroquinone at concentrations above 2% for use on the skin will be added to the Prescription Drug List. These products will be available by prescription only, under the oversight of a healthcare professional, rather than without a prescription.
Information Update - Hydroquinone
Unauthorized health products
Health Canada advised Canadians about various unauthorized health products being sold at retail locations across Canada or online that may pose serious health risks.
Advisory - Aerobic Oxygen
Advisory - Kobayashi Eyebon Eyewash
Advisory - Poppers and sexual enhancement products
Advisory - Product containing synthetic cannabinoids
Advisory - Psychotic by Insane Labz
Advisory - Sexual enhancement products
Page details
- Date modified: